Reconstitution of Human Thymic Implants Is Limited by Human Immunodeficiency Virus Breakthrough during Antiretroviral Therapy

Human immunodeficiency virus type 1 (HIV-1)-infected SCID-hu thymic implants depleted of CD4(+) cells can support renewed thymopoiesis derived from both endogenous and exogenous T-cell progenitors after combination antiretroviral therapy. However, successful production of new thymocytes occurs trans...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Amado, Rafael G., Jamieson, Beth D., Cortado, Ruth, Cole, Steve W., Zack, Jerome A.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Pathogenesis and Immunity
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112715/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10400728/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.8.6361-6369.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!